These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38044985)

  • 21. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
    Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
    J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of second cancer among young prostate cancer survivors.
    Zhang H; Yu A; Baran A; Messing E
    Radiat Oncol J; 2021 May; 39(2):91-98. PubMed ID: 34619825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Cancers After Radiation Therapy for Primary Prostate or Rectal Cancer.
    Lee YC; Hsieh CC; Li CY; Chuang JP; Lee JC
    World J Surg; 2016 Apr; 40(4):895-905. PubMed ID: 26711638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary on "secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention." Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.: BJU Int 2012;110:1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. [Epub 2012 Aug 13].
    Gottschalk A
    Urol Oncol; 2014 Feb; 32(2):209. PubMed ID: 24445290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.
    Jahreiß MC; Heemsbergen WD; Janus C; van de Pol M; Dirkx M; Dinmohamed AG; Nout RA; Hoogeman M; Incrocci L; Aben KKH
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e278-e288. PubMed ID: 36725405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
    Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
    BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis.
    Wu D; Yang Y; Jiang M; Yao R
    BMC Urol; 2022 Mar; 22(1):42. PubMed ID: 35331219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer.
    Chin CP; Smith WH; Cesaretti J; Terk M; Garden EB; Araya JS; Palese MA; Stock RG; Buckstein M
    Urol Oncol; 2023 Jun; 41(6):296.e9-296.e16. PubMed ID: 36588020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
    Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
    Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy.
    Matsuo K; Vallejo A; Barakzai SK; Nusbaum DJ; Machida H; Ciccone MA; Roman LD
    Eur J Surg Oncol; 2023 Feb; 49(2):461-467. PubMed ID: 36064632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.
    Liu D; Kuai Y; Zhu R; Zhou C; Tao Y; Han W; Chen Q
    Sci Rep; 2020 Jun; 10(1):9104. PubMed ID: 32499554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
    Hoffman KE; Hong TS; Zietman AL; Russell AH
    Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy for prostate cancer increases the risk of subsequent rectal cancer.
    Margel D; Baniel J; Wasserberg N; Bar-Chana M; Yossepowitch O
    Ann Surg; 2011 Dec; 254(6):947-50. PubMed ID: 22107741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis.
    Tang W; Zhou LJ; Zhang WQ; Jia YJ; Ge MW; Hu FH; Chen HL
    Tech Coloproctol; 2023 Dec; 28(1):14. PubMed ID: 38095784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries.
    Li W; Xiao H; Xu X; Zhang Y
    Curr Oncol; 2021 Jan; 28(1):301-316. PubMed ID: 33435562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
    Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
    Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT
    J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
    Andruska N; Agabalogun T; Fischer-Valuck BW; Brenneman RJ; Huang Y; Gay HA; Michalski JM; Carmona R; Baumann BC
    Brachytherapy; 2022; 21(5):617-625. PubMed ID: 35641370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer.
    Johnson SB; Lester-Coll NH; Kelly JR; Kann BH; Yu JB; Nath SK
    Eur Urol; 2017 Nov; 72(5):738-744. PubMed ID: 28688613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.